Literature DB >> 24108451

Bringing testing to the people - benefits of mobile unit HIV/syphilis testing in Lima, Peru, 2007-2009.

Mindy C Lipsitz1, Eddy R Segura, José Luis Castro, Edward Smith, Carlos Medrano, Jesse L Clark, Jordan E Lake, Robinson Cabello.   

Abstract

Mobile unit (MU) HIV testing is an alternative method of providing healthcare access. We compared demographic and behavioural characteristics, HIV testing history and HIV prevalence between participants seeking testing at a MU vs. fixed clinic (FC) in Lima, Peru. Our analysis included men and transgender women (TW) in Lima aged ≥ 18 years old seeking HIV testing at their first visit to a community-based MU or FC from October 2007 to November 2009. HIV testing history, HIV serostatus and behavioural characteristics were analysed. A large percentage of MU attendees self-identified as transgender (13%) or heterosexual (41%). MU attendees were more likely to engage in transactional sex (24% MU vs. 10% FC, p < 0.001), use alcohol/drugs during their last sexual encounter (24% MU vs. 20% FC, p < 0.01) and/or be a first-time HIV tester (48% MU vs. 41% FC, p < 0.001). MU HIV prevalence was 9% overall and 5% among first-time testers (49% in TW and 11% in men who have sex with men [MSM] first-time testers). MU testing reached large numbers of at-risk (MSM/TW) populations engaged in unsafe sexual behaviours, making MU outreach a worthy complement to FC testing. Investigation into whether MU attendees would otherwise access HIV testing is warranted to determine the impact of MU testing.

Entities:  

Keywords:  AIDS; HIV; HIV prevention techniques; MSM; Peru; alternative HIV testing strategies; diagnosis; men who have sex with men; mobile unit testing; sexually transmitted infection; transgender women

Mesh:

Year:  2013        PMID: 24108451      PMCID: PMC4110635          DOI: 10.1177/0956462413507443

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  14 in total

1.  Understanding the HIV/AIDS epidemic in transgender women of Lima, Peru: results from a sero-epidemiologic study using respondent driven sampling.

Authors:  Alfonso Silva-Santisteban; H Fisher Raymond; Ximena Salazar; Jana Villayzan; Segundo Leon; Willi McFarland; Carlos F Caceres
Journal:  AIDS Behav       Date:  2012-05

2.  Comparison of clients of a mobile health van and a traditional STD clinic.

Authors:  Jonathan M Ellen; Sekhar Bonu; Jaime S Arruda; Michael A Ward; Ruth Vogel
Journal:  J Acquir Immune Defic Syndr       Date:  2003-04-01       Impact factor: 3.731

3.  HIV-1, sexually transmitted infections, and sexual behavior trends among men who have sex with men in Lima, Peru.

Authors:  Jorge Sanchez; Javier R Lama; Lourdes Kusunoki; Hugo Manrique; Pedro Goicochea; Aldo Lucchetti; Manuel Rouillon; Monica Pun; Luis Suarez; Silvia Montano; Jose L Sanchez; Stephen Tabet; James P Hughes; Connie Celum
Journal:  J Acquir Immune Defic Syndr       Date:  2007-04-15       Impact factor: 3.731

4.  HIV seropositivity rates in outreach-based counseling and testing services: program evaluation.

Authors:  W DiFranceisco; D R Holtgrave; N Hoxie; W J Reiser; R Resenhoeft; S D Pinkerton; J Vergeront
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-11-01

5.  Strategies for syphilis prevention: findings from surveys in a high-incidence area.

Authors:  T A Farley; R H Kahn; G Johnson; D A Cohen
Journal:  Sex Transm Dis       Date:  2000-07       Impact factor: 2.830

6.  HIV, syphilis and heterosexual bridging among Peruvian men who have sex with men.

Authors:  Stephen Tabet; Jorge Sanchez; Javier Lama; Pedro Goicochea; Pablo Campos; Manuel Rouillon; Jose Luis Cairo; Lucia Ueda; Douglas Watts; Connie Celum; King K Holmes
Journal:  AIDS       Date:  2002-06-14       Impact factor: 4.177

7.  Community-based screening and treatment for STDs: results from a mobile clinic initiative.

Authors:  Richard H Kahn; Kera E Moseley; John N Thilges; Gwendolyn Johnson; Thomas A Farley
Journal:  Sex Transm Dis       Date:  2003-08       Impact factor: 2.830

8.  Project Accept (HPTN 043): a community-based intervention to reduce HIV incidence in populations at risk for HIV in sub-Saharan Africa and Thailand.

Authors:  Gertrude Khumalo-Sakutukwa; Stephen F Morin; Katherine Fritz; Edwin D Charlebois; Heidi van Rooyen; Alfred Chingono; Precious Modiba; Khalifa Mrumbi; Surasing Visrutaratna; Basant Singh; Michael Sweat; David D Celentano; Thomas J Coates
Journal:  J Acquir Immune Defic Syndr       Date:  2008-12-01       Impact factor: 3.731

9.  Risk behaviors and reasons for not getting tested for HIV among men who have sex with men: an online survey in Peru.

Authors:  Magaly M Blas; Isaac E Alva; Robinson Cabello; Cesar Carcamo; Ann E Kurth
Journal:  PLoS One       Date:  2011-11-09       Impact factor: 3.240

Review 10.  A systematic review of qualitative findings on factors enabling and deterring uptake of HIV testing in Sub-Saharan Africa.

Authors:  Maurice Musheke; Harriet Ntalasha; Sara Gari; Oran McKenzie; Virginia Bond; Adriane Martin-Hilber; Sonja Merten
Journal:  BMC Public Health       Date:  2013-03-11       Impact factor: 3.295

View more
  23 in total

1.  Venue-Based HIV-Testing: An Effective Screening Strategy for High-Risk Populations in Lima, Peru.

Authors:  Lao-Tzu Allan-Blitz; M Christina Herrera; Gino M Calvo; Silver K Vargas; Carlos F Caceres; Jeffrey D Klausner; Kelika A Konda
Journal:  AIDS Behav       Date:  2019-04

2.  The Relationship Between Risk Perception and Frequency of HIV Testing Among Men Who Have Sex with Men and Transgender Women, Lima, Peru.

Authors:  S K Vargas; K A Konda; S R Leon; B Brown; J D Klausner; C Lindan; C F Caceres
Journal:  AIDS Behav       Date:  2018-07

3.  Partner-Level Factors Associated with Insertive and Receptive Condomless Anal Intercourse Among Transgender Women in Lima, Peru.

Authors:  Milan F Satcher; Eddy R Segura; Alfonso Silva-Santisteban; Jorge Sanchez; Javier R Lama; Jesse L Clark
Journal:  AIDS Behav       Date:  2017-08

4.  Feasibility of Using HIV Care-Continuum Outcomes to Identify Geographic Areas for Targeted HIV Testing.

Authors:  Amanda D Castel; Irene Kuo; Meriam Mikre; Toni Young; Meredith Haddix; Suparna Das; Geoffrey Maugham; Carol Reisen
Journal:  J Acquir Immune Defic Syndr       Date:  2017-02-01       Impact factor: 3.731

Review 5.  HIV Testing Strategies, Types of Tests, and Uptake by Men Who have Sex with Men and Transgender Women: A Systematic Review and Meta-analysis.

Authors:  Laio Magno; Marcos Pereira; Caroline Tianeze de Castro; Thais Aranha Rossi; Laylla Mirella Galvão Azevedo; Nathalia Sernizon Guimarães; Ines Dourado
Journal:  AIDS Behav       Date:  2022-08-19

Review 6.  Facilitators and barriers to point-of-care testing for sexually transmitted infections in low- and middle-income countries: a scoping review.

Authors:  Kevin Martin; Rhys Wenlock; Tom Roper; Ceri Butler; Jaime H Vera
Journal:  BMC Infect Dis       Date:  2022-06-20       Impact factor: 3.667

Review 7.  Challenges in managing HIV in people who use drugs.

Authors:  Adeeba Kamarulzaman; Frederick L Altice
Journal:  Curr Opin Infect Dis       Date:  2015-02       Impact factor: 4.915

Review 8.  HIV risk and preventive interventions in transgender women sex workers.

Authors:  Tonia Poteat; Andrea L Wirtz; Anita Radix; Annick Borquez; Alfonso Silva-Santisteban; Madeline B Deutsch; Sharful Islam Khan; Sam Winter; Don Operario
Journal:  Lancet       Date:  2014-07-22       Impact factor: 79.321

Review 9.  Expanding syphilis testing: a scoping review of syphilis testing interventions among key populations.

Authors:  Jason J Ong; Hongyun Fu; M Kumi Smith; Joseph D Tucker
Journal:  Expert Rev Anti Infect Ther       Date:  2018-04-23       Impact factor: 5.091

Review 10.  The Prevalence of HIV Among Men Who Have Sex With Men (MSM) and Young MSM in Latin America and the Caribbean: A Systematic Review.

Authors:  Lara E Coelho; Thiago S Torres; Valdilea G Veloso; Beatriz Grinsztejn; Emilia M Jalil; Erin C Wilson; Willi McFarland
Journal:  AIDS Behav       Date:  2021-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.